Show/Hide Menu

MorphoSys's vision

MorphoSys is committed to develop exceptional new treatments for patients suffering from serious diseases. A leader in the field of therapeutic antibodies today, MorphoSys is driven by the ambition of creating the most valuable pipeline of biopharmaceuticals in the biotechnology industry.

Events

08. Mon
January

JP Morgan Healthcare Conference 2018

San Francisco, CA, USA
15. Mon
January

Kepler Cheuvreux German Corporate Conference

Frankfurt, Germany
14. Wed
February

LEERINK Partners 7th Annual Global Healthcare Conference

New York, USA

Presentations

12/12/2017
Investor & Analyst Presentation after the 2017 ASH Annual Meeting
12/06/2017
Berenberg European Conference 2017
Pennyhill, UK
11/27/2017
Deutsches Eigenkapitalforum 2017
Frankfurt, Germany
11/16/2017
Bryan Garnier Healthcare Conference
Paris, France
11/07/2017
Q3 2017 Financial Results
Planegg, Germany

Media and investors

Anke Linnartz

Vice President, Head of Corporate Communications and IR

Phone: +49 89 89927 404

Fax: +49 89 89927 5404

Email Contact
LinkedIn-Profile

Alexandra Goller

Senior Manager Corporate Communications and Investor Relations

Phone: +49 89 89927 404

Fax: +49 89 89927 5404

Email Contact
LinkedIn-Profile

Jochen Orlowski

Associate Director Corporate Communications and Investor Relations

Phone: +49 89 89927 404

Fax: +49 89 89927 5404

Email Contact